References
- Diamond RD, Bennett JE: Prognostic factors in cryptococcal meningitis: A study of 111 cases. Ann Intern Med 80:176, 1974
- Sheil AG, Mears D, Kelly GE, et al: A controlled trial of antilymphocyte globulin therapy (ALG) in man. Transplant Proc 4:501–505, 1972
- Diamond RD: Antibody-dependent killing of Cryptococcus neoformans by human peripheral blood mononuclear cells. Nature 247:148, 1974
- Farmer SG, Komorowski RA: Histologic response to capsule-deficient Cryptococcus neoformans. Arch Pathol 96:383, 1973
- Young RC, Bennett JE, Geelhoed GW, et al: Fungemia with compromised host resistance: A study of 70 cases. Ann Intern Med 80:605, 1974
- Butler WT, Alling DW, Spickard A, et al: Diagnostic and prognostic value of clinical and laboratory findings in cryptococcal meningitis, a follow-up study of forty patients. N Engl J Med 270:59, 1964
- Diamond RD, May JE, Kane MA, et al: The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection. J Immunol 112:2260, 1974
- Mohr JA, Muchmore HG, Tacker R: Stimulation of phagocytosis of Cryptococcus neoformans in human cryptococcal meningitis. J Reticuloendothel Soc 15:149, 1974
- Diamond RD, May JE, Kane M, et al: The role of late complement components and the alternate complement pathway in experimental cryptococcosis. Proc Soc Exp Biol Med 144:312, 1973
- Turcotte JG: Infection and renal transplantation. Surg Clin North Am 52:1501, 1972
- Morrelli HF, Drutz DJ: Antibiotic therapy in compromised hosts. Calif Med 119:49, 1973
- Mohr JA, Tatem BA, Long H, et al: Increased susceptibility of Cryptococcus neoformans to amphotericin B in the presence of steroids. Sabouraudia 11:140, 1973